+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eszopiclone"

Insomnia Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Insomnia Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
Sedative-Hypnotic Drugs Market Report 2025 - Product Thumbnail Image

Sedative-Hypnotic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 898 Pages
  • Global
From
From
Chronic Insomnia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Insomnia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Eszopiclone is a nonbenzodiazepine hypnotic drug used to treat insomnia. It is classified as a central nervous system (CNS) drug and is a member of the cyclopyrrolone family. Eszopiclone works by binding to the same receptors as benzodiazepines, but with a different chemical structure. It is believed to have fewer side effects than benzodiazepines, and is generally considered to be safer and more effective. Eszopiclone is available in both generic and brand-name forms, and is typically prescribed for short-term use. Eszopiclone is used to treat a variety of sleep disorders, including difficulty falling asleep, difficulty staying asleep, and early morning awakenings. It is also used to treat insomnia caused by jet lag or shift work. Eszopiclone is not recommended for long-term use, as it can lead to dependence and tolerance. Some companies in the Eszopiclone market include Sunovion Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more